|
China Pharma Holdings Inc (NYSE: CPHI) |
|
China Pharma Holdings Inc
CPHI's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Looking into China Pharma Holdings Inc growth rates, revenue grew
by 0.21 % in III. Quarter 2024 from the same quarter a year ago.
Ranking at No. 2116
Major Pharmaceutical Preparations industry recorded
growth of revenues by 9.76 %
China Pharma Holdings Inc net loss increased from $-1 millions, to $-1 millions in III. Quarter 2024,
• More on CPHI's Growth
|
|
China Pharma Holdings Inc realized a net loss in trailing twelve months.
China Pharma Holdings Inc realized cash reduction of $ -0.01 per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 0.88.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.27.
• More on CPHI's Valuation
|
|
|
|
|
China Pharma Holdings Inc realized net loss in trailing twelve months.
China Pharma Holdings Inc realized cash outflow of $ -0.01per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 0.88.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.27.
China Pharma Holdings Inc Price to Book Ratio is at 0.7 lower than Industry Avg. of 90.03. and higher than S&P 500 Avg. of 0.01
• More on CPHI's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com